Becton Dickinson and BDX experienced a mixed bag of financial results in the past years. Despite a
4.7% loss from investments made five years ago,
Caprock Group LLC and
Charles Schwab Investment Management Inc have increased their stake while
Ontario Teachers Pension Plan bought an additional 223,879 shares. The company's
Q4 earnings surpassed Wall Street estimates, revealing a strong revenue growth.
BD made significant moves like the launch of its HPV Self-Collection Study targeting cervical cancer screening in underserved communities, acquisition of Critical Care from Edwards Lifesciences that positioned it as a leader in advanced monitoring technology and launching of a Robotics Solution to enhance single-cell research. Financial metrics like the
Growth Rank and Earnings Per Share (EPS) without NRI have been positive. The company received a
consensus recommendation of 'Buy' from brokerages and some investors believe the
stock is undervalued.
Becton Dickinson and BDX News Analytics from Mon, 11 Mar 2024 07:00:00 GMT to Sat, 23 Nov 2024 12:11:18 GMT -
Rating 6
- Innovation 5
- Information 8
- Rumor -5
